Delivery Order SPE2DB24D2013-SPE2DB24FCHBN

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,067.78 order is for the supply of 4,564,451,583 units of the pharmaceutical product Gabapentin 600 mg tablets. The award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for 4,565,470,262 units of Gabapentin 600 mg tablets and has a ceiling value of $1,474.56. It is a firm fixed price contract type with an ultimate completion date of August 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company holds several Indefinite Delivery Contracts...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565442175 Gabapentin 800 mg tablets. The $2,527.06 firm-fixed-price contract has an estimated completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of gabapentin 800 mg tablets. The order, valued at $3,227.98, is a firm fixed-price contract with a period of performance through January 21, 2025. The contract is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,931,039 units of gabapentin 300mg tablets, a prescription medication. The contract has a ceiling value of $9,014.80 and an ultimate completion date of October 22, 2024. The contract is a firm fixed price Delivery Order with no set-aside designation. Amerisourcebergen has been awarded...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,552.14, is for the delivery of 4567036306 - Gabapentin 600 mg tablets. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,924,465 Gabapentin 800 mg tablets. The firm-fixed price contract, with a ceiling value of $1,923.48, has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these prescription medications to support military treatment facilities and other federal healthcare providers. The contract is not designated as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gabapentin 800 mg tablets. The contract, valued at $2,016.96, is a Delivery Order issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 600mg Gabapentin tablets, a medication commonly used to treat nerve pain and other conditions. The contract has a ceiling value of $1,079.88 and runs through October 25, 2024. It is a firm fixed-price contract, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 800 mg gabapentin tablets. The contract has a ceiling value of $2,012.40 and an ultimate completion date of July 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. This contract is part of a larger Indefinite Delivery Contract...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB24FCHBN
    Delivery Order

This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to supply 4,564,996 units of the prescription medication gabapentin 600 mg tablets. The award has a ceiling value of $3,209.70 and a period of performance through June 26, 2024. This order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a wide range of pharmaceutical products and medical supplies to support U.S. military treatment programs and facilities globally. This particular order does not have a set-aside designation.

Generated 9/24/24, 9:36 AM